Education
Pepperdine University
BS/BA Business Administration
I am witnessing a world of pain. Bright, young digital health and medical device companies are struggling with raising capital and building a reliable business/revenue model. I have been there…five times over. Paying it forward, I enjoy helping young companies achieve their potential. I help by sharing experience and learnings from my 30 years as a entrepreneur and healthcare/life sciences/MedTech executive. I tell them that I have made many mistakes and I will guide them to avoid my mistakes to accelerate their success.
Over the past decade, I have provided hands-on support to dozens of young companies in the UK, EU, and US to uncover their unique, optimal pathways to success.
I am now formalizing these skills into a consulting practice, and I’d like to help you or a young company you know achieve your ambitions. My practice is called a priori.
A priori means “knowledge that comes from the power of reasoning based on self-evident truths.”
My intention is to provide rapid assessment, evidence-based recommendations, and operational support to ameliorate the pain of early-stage business growth, with special emphasis on digital health and MedTech companies.
Unfabled - Serve as advisor and investor in this innovative Women's Health platform
MindinFlow - Service as advisor for this neurotherapy and coaching services approach using evidence-based, non-invasive, and tailored applications to address anxiety, ADHD, and insomnia.
zNeurosciences - Developed commercial strategy for this nutraceutical company focused on evidence-based products for aging and neurodegenerative diseases.
EVocal Health - Developed business plan for this biopharmaceutical digital health company that unlocks the human voice as a biomarker for health and longevity.
Levy Health - Served as yearlong commercial advisor for this clinical decision support software for reproductive care experts to empower women’s healthcare professionals to treat more patients.
Mon4T - Developed clinical and commercial strategies and drive early revenues for this neurology technology company that turns standard smartphones into a sophisticated, personalized neurological medical testing devices. Helped define the target customers among telemedicine and pharmaceutical companies, hospitals, and researchers to use clinically validated tools for remote and in-person testing and monitoring of neurological and psychiatric patients.
Established US beachhead and operations for UK company PneumoWave, LTD, an AI company saving lives by detecting and alerting overdoses from substance use disorder. PneumoWave has developed a Remote Digital Behavioral Health Platform to provide care teams with a range of validated digital technologies to enable more effective/efficient assessment and remote management of patients w/ Opioid Use Disorder. PneumoWave is driven to save lives.
As a FDA Breakthrough designated digital health and therapeutics company, it has developed an innovative platform for the capture and analysis of longitudinal respiratory data. It uses this data to derive metric with clinical utility in acute and chronic respiratory conditions.
Scotland has the second largest number of opioid deaths per capita behind the US. PneumoWave has conducted 7 clinical studies in the UK, EU, and Australia and engaged with similarly recognized partners to replicate these studies in the US. Planned research aims to evaluate not only the clinical impact but also the positive economic, epidemiological, and public health impact that may result from the implementation and ongoing adoption of overdose detection technology.
nQ is a computational biotechnology company that builds powerful machine learning solutions supporting the continuum of neurological health using its AI-powered Digital Biomarker Discovery Platform (DBDP). The DBDP was developed from 8 years of clinical studies and phenotypes neurodegenerative diseases through passive, AI-aided analysis of personal device interactions. Its biomarkers are used for early detection (years earlier than gold standard), uses RWD to track disease progression over time. Because it tracks disease progression, it can measure the impact of therapy (Rx, device, or CBT).–nQ's FDA Breakthrough designated SaMD has been developed for Parkinson's as its first indication in early-stage diagnosis up to 10 years post-diagnosis. Studies are ongoing in Alzheimer's. ALS, Huntington's, and Multiple Sclerosis. In prodromal stages of neurodegenerative diseases, digital biomarkers can detect sub-clinical symptoms known to predict phenoconversion better than biochemical markers.
As CEO, hired and managed teams supporting Clinical Research, Data Science, Engineering, and Regulatory Strategy. Wrote business plan and pivoted coming out of COVID to new revenue pathways in RPM and CCM. Founded in 2016. Currently has 16 employees. Raised $14M USD in capital to Series A.
Notable Contributions:
Founded organization in partnership with Capgemini to reshape dynamics of how healthcare stakeholders (life science manufacturers, healthcare practitioners, payors, and patients) interact/transact to achieve mutual objectives. Case Study: Digital Transformation of the Pharma Sales Model.
Oversaw/led domestic and global offices in Hartford, Connecticut and Paris, France. Lead branding and market positioning exercises and promote conversations via direct input into what HCPs constitute as real value.
Lead development of custom technology platform to support interaction among/between life science personnel; provide patented, license-free and maintenance-free tools to facilitate transactions among stakeholders.
Utilize extensive IT and leadership skills to deliver relevant information, services, and products to subscribers. Promote the transaction model to freelance and entrepreneurial salespersons.
Notable Contributions:
Built the company to $65M in net revenues. Managed 200+ employees in four states: CA, PA, NC, and CT (HQ). Created, organized, implemented, and drove strategy to assist Fortune 100 pharmaceutical and medical device industry meet desired marketing objectives.
Partnered with world-renowned physicians, pharmacists, and healthcare executives to further organizational goals. Collaborated with medical professional organizations, e.g., JCAHO, ACS, AAHP, ASHSP, AHA, and NAHQ.
Created national marketing strategies for products in a variety of medical fields for clients Amgen, Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Merck, Novartis, Pfizer, Sanofi-Aventis, et al.
Notable Contributions:
After three years of success as marketing manager, I was promoted to head of all accounts for all 21 Pharmedica clients worldwide.
I made a career transition from hospitals and healthcare to pharmaceuticals. The timing was impeccable as healthcare transitioned from retrospective to prospective reimbursement, and Pharma companies needed guidance on modifying sales and marketing practices.
Primarily managed the Pfizer account. Launched several Rx, including Zoloft, Aricept, Geodon, and Viagra.
My most notable accomplishment was the launch of Zoloft 6000: Signs, Symptoms, and Care. This program eventually became National Depression Screening Day. The project involved all 6,000 US hospitals and laid the groundwork for Zoloft to surpass Prozac as the leading SSRI. The initiative was the ONLY medical education program featured in https://www.abebooks.com/first-edition/CELEBRATING-PFIZER-150-YEARS-INNOVATION-1849/17743602210/bd
Developed and marketed software solutions to pharmaceutical and medical devices industries. Created sales and marketing strategy, new product development, and client servicing for North American and global EMEA (Europe, Middle East, Africa) business operations. Named by PharmaVOICE Top 100 Most Influential People in Pharma - The RISK TAKERS
Notable Contributions:
Drove marketing research and established best practices within the facility. Developed marketing plans for product line introductions; coordinated new technology training for physicians and community members.
Conducted market research, patient satisfaction surveys, and community/corporate wellness programs.
Marketed existing practices and recruited new physicians; led physician/healthcare referral service.
Led in-house graphic design and audio-visual production in marketing endeavors. Created and published an award-winning quarterly community health magazine distributed to 65,000 area households.
Notable Contributions:
Planned/organized public affairs, marketing, and fundraising activities; ensured the hospital was viewed positively within the community. Implemented/built all public relations and fundraising programs from the bottom up.
Conducted extensive marketing throughout 2-state area. Implemented research, media relations, publication production, graphic design, fundraising, and image development.
Utilized public relations knowledge to collaborate on legislative and community affairs issues.
Furthered organizational goals by joining committees, such as Long Range Plan Development, Patient Care Assessment, and Job Evaluation.
Notable Contributions:
Build things. I enjoy construction, landscaping, building businesses, and leading committees to support worthwhile endeavors. Building things that make a significant difference in people's lives. For my college summer job, I worked for a company that built government housing. We had one team that did everything from digging the hole for the foundation, pouring the cement, framing the house, finishing the electrical and plumbing, etc., to rolling out the turf for the lawn. We had a saying, "It'll catch," meaning that no matter how well or how poorly you laid the turf, it would grow in. I learn many skills during those summers. All of which I have put to use today.
bavassoceo@gmail.com | 8603733174